Login / Signup

Targeting ZNF410 as a potential β-hemoglobinopathy therapy.

Laxminath TumburuSwee Lay Lay Thein
Published in: Nature genetics (2021)
Keyphrases
  • cancer therapy
  • human health
  • stem cells
  • risk assessment
  • drug delivery